WHO

World Health Organization

InternationalInternationalInternational harmonizer

Publishes GMP/GDP guidance via Technical Report Series (TRS) referenced by many emerging-market regulators.

Browse the WHO standards →Official site ↗

What this page does not claim

SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.

WHAT WHO COVERS

The World Health Organization sets normative standards for medicines quality and access, publishing GMP, GDP, and related guidance through its Technical Report Series. Its standards are especially consequential for markets whose national regulations reference WHO guidance directly, and for products procured by UN agencies.

WHAT WHO PUBLISHES

  1. 01Technical Report Series (TRS) annexes — WHO GMP for pharmaceutical products, APIs, and specific categories
  2. 02WHO Prequalification lists for medicines, vaccines, and diagnostics
  3. 03Guidance on data integrity (TRS 1033 Annex 4) and on GDP
  4. 04The International Pharmacopoeia
  5. 05The WHO-Listed Authority framework for evaluating regulatory maturity

HOW ITS REQUIREMENTS BITE

WHO has no enforcement power. Its guidance carries weight in two practical ways: national regulators adopt it into their own binding rules, and the WHO Prequalification Programme assesses medicines, vaccines, diagnostics, and manufacturing sites for suitability for UN and donor procurement — an assessment that functions much like a regulatory approval for those channels.

What practitioners get wrong

  • WHO GMP is the baseline that many national frameworks in emerging markets adopt more or less directly.
  • Prequalification is a distinct route with its own dossier and inspection expectations — not a substitute for national approval.
  • TRS annexes are numbered by report; cite the annex, not just the report number.
  • The WHO-Listed Authority designation is increasingly used by regulators as a basis for reliance.
PROFESSIONAL · INSPECTION INTELLIGENCE · SPEQ SYNTHESIS

What an inspection under this authority actually probes

CHECKING ACCESS

Checking your Professional access…

WHERE IT SITS INTERNATIONALLY

WHO guidance underpins many national GMP regimes and is closely aligned in substance with PIC/S. Its Listed Authority framework is becoming the common language for regulatory reliance between countries.

WHO STANDARDS SPEQ DECODES · 7

WHO TRS 957, Annex 5
WHO Good Distribution Practices for Pharmaceutical Products
WHO GCLP (2009)
Good Clinical Laboratory Practice (GCLP)
WHO TRS 986, Annex 2HIGH INSPECTION RISK
WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles
WHO TRS 996, Annex 5HIGH INSPECTION RISK
WHO Guidance on Good Data and Record Management Practices
WHO TRS 961, Annex 9
Model Guidance for the Storage and Transport of Time- and Temperature-Sensitive Pharmaceutical Products
Ph. Int. (12th ed.)
The International Pharmacopoeia
WHO LBM 4th ed. (2020)
Laboratory Biosafety Manual, Fourth Edition

DISCIPLINES IN WHO’S REMIT

GMPGood Manufacturing PracticeGDPGood Distribution PracticeGDocPGood Documentation PracticeGCLPGood Clinical Laboratory Practice
TOPIC EXPLAINERS CITING WHO STANDARDS
Cold Chain & Temperature Control in Distribution →
How Good Distribution Practice keeps a medicine within its qualified temperature range from the factory to the patient — mapping, the qualified cold chain, and what an excursion actually means.
Temperature Excursion Management →
Handling a temperature excursion in distribution — stability-budget assessment, quarantine, and the release-or-reject decision.
Transport Qualification in GDP →
Qualifying shipping lanes, packaging, and vehicles so medicines stay in condition from dispatch to delivery.
Returns & Recalls in Distribution →
How distributors handle returned medicines, execute recalls, and keep falsified product out of the legitimate supply chain.
Bioanalytical Method Validation →
Validating the assays that measure drug in biological matrices — selectivity, calibration, accuracy, precision, and stability.
Records, Content & Retrieval →
A record that cannot be found within the time an inspection allows is functionally missing.
Biosafety & Biological Containment →
Containment protects people from the product; cleanroom design protects the product from people — and they impose opposite pressure regimes.

WHO: frequently asked questions

Reference answers on World Health Organization’s mandate, what it publishes, and how its requirements acquire force.

What GxP standards does the WHO publish?

The World Health Organization publishes GMP, GDP, and related guidance through its Technical Report Series, plus the International Pharmacopoeia. WHO GMP is the baseline that many national frameworks in emerging markets adopt more or less directly. Cite the TRS annex, not just the report number.

Can the WHO enforce its standards?

No, WHO has no enforcement power. Its guidance carries weight when national regulators adopt it into binding rules, and through the WHO Prequalification Programme, which assesses medicines, vaccines, diagnostics, and sites for UN and donor procurement — functioning much like a regulatory approval for those channels.

What is a WHO-Listed Authority?

The WHO-Listed Authority framework evaluates regulatory maturity and is increasingly used by regulators as a basis for reliance. WHO guidance underpins many national GMP regimes and is closely aligned in substance with PIC/S.